KCM
AGN

Kingdon Capital Management’s Allergan plc AGN Stock Holding History

Kingdon Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60,000
Closed -$18.8M – 149
2015
Q4 		$18.8M Buy
+60,000
New +$17.9M 0.91% 32

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Kingdon Capital Management's AGN Position: Q4 2019 in Review

Kingdon Capital Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 60,216 shares — an estimated $10.1M sold.

Kingdon Capital Management first reported a position in AGN in Q3 2013 and held it in 13 quarters. The position peaked at $48.8M in Q4 2014. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Kingdon Capital Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Kingdon Capital Management sold 60,216 Allergan plc shares in Q4 2019, an estimated $10.1M.
  • Kingdon Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 13 quarters.
  • Kingdon Capital Management's Allergan plc position peaked at $48.8M in Q4 2014.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Kingdon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.